[1]潘福璐 罗志强 杨文宁 韩星 于国华 潘艳丽.UHPLC-LTQ-Orbitrap测定异类叶升麻苷在大鼠尿液中的代谢产物[J].国际中医中药杂志,2020,42(09):889-894.[doi:10.3760/cma.j.cn115398-20200103-00029]
 Pan Fulu,Luo Zhiqiang,Yang Wenning,et al.Analysis of the metabolites of isoacteoside in rat urine by UHPLC-LTQ-Orbitrap[J].,2020,42(09):889-894.[doi:10.3760/cma.j.cn115398-20200103-00029]
点击复制

UHPLC-LTQ-Orbitrap测定异类叶升麻苷在大鼠尿液中的代谢产物

参考文献/References:

[1] Sun M,Luo Z,Liu Y,et al. Identification of the Major Components of Buddleja officinalis Extract and Their Metabolites in Rat Urine by UHPLC-LTQ-Orbitrap[J]. J Food Sci,2016, 81(10):H2587-H2596. DOI:10.1111/1750-3841.13435.

[2] Zhou J,Zhang Q,Sun JB,et al. Two-phase hollow fiber liquid phase microextraction based on magnetofluid for simultaneous determination of Echinacoside,Tubuloside B,Acteoside and Isoacteoside in rat plasma after oral administration of Cistanche salsa extract by high performance liquid chromatography[J]. J Pharm Biomed Anal,2014,94:30-35. DOI:10.1016/j.jpba. 2014.01.013.

[3] Li L,Tsao R,Liu Z,et al. Isolation and purification of acteoside and isoacteoside from Plantago psyllium L. by high-speed counter-current chromatography[J]. J Chromatogr A,2005, 1063(1/2):161-169. DOI:10.1016/j.chroma.2004.11.024.

[4] Gao H,Cui Y,Kang N,et al. Isoacteoside,a dihydroxyphenylethyl glycoside,exhibits anti-inflammatory effects through blocking toll-like receptor 4 dimerization[J]. Br J Pharmacol,2017, 174(17):2880-2896. DOI:10.1111/bph.13912.

[5] Shiao YJ,Su MH,Lin HC,et al. Acteoside and Isoacteoside Protect Amyloid β Peptide Induced Cytotoxicity,Cognitive Deficit and Neurochemical Disturbances In Vitro and In Vivo[J]. Int J Mol Sci,2017,18(4):1-16. DOI:10.3390/ijms 18040895.

[6] Yang X,Guo F,Peng Q,et al. Suppression of in vitro and in vivo human ovarian cancer growth by isoacteoside is mediated via sub-G1 cell cycle arrest,ROS generation,and modulation of AKT/PI3K/m-TOR signalling pathway[J]. J BUON,2019, 24(1):285-290.

[7] Chae S,Kim JS,Kang KA,et al. Antioxidant activity of isoacteoside from Clerodendron trichotomum[J]. J Toxicol Environ Health A,2005,68(5):389-400. DOI:10.1080/ 15287390590900750.

[8] Zeng X,Wang J,Zhang W,et al. Anti-gout Effects of Plantago asiatica:Xanthine Oxidase Inhibitory Activities Assessed by Electrochemical Biosensing Method [J]. Evid Based Compl Alt Med,2018,2018(9):1-11. DOI:10.1155/2018/1364617.

[9] Chukwuma CI,Matsabisa MG,Ibrahim MA,et al. Medicinal plants with concomitant anti-diabetic and anti-hypertensive effects as potential sources of dual acting therapies against diabetes and hypertension:A review[J]. J Ethnopharmacol, 2019,235:329-360. DOI:10.1016/j.jep.2019.02.024.

[10] Wang W,Jiao L,Tao Y,et al. On-line HPLC-DPPH bioactivity- guided assay for isolated of antioxidative phenylpropanoids from Qinghai-Tibet Plateau medicinal plant Lancea tibetica[J]. J Chromatogr B Analyt Technol Biomed Life Sci,2019, 1106/1107:1-10. DOI:10.1016/j.jchromb.2018.12.029.

[11] 李川. 中药多成分药代动力学研究:思路与方法 [J]. 中国中药杂志,2017,42(4):607-617. DOI:10.19540/j.cnki.cjcmm. 2017.0016.

[12] 王晶娟,刘洋,赵保胜,等. 中药“质效代关联”研究方法与理论的建立[J]. 中草药,2014,45(11):1507-1510. DOI:10. 7501/j.issn.0253-2670.2014.11.001.

[13] 何雪莲,秦付林,任华忠. 中药复方药效物质基础研究方法探析[J]. 亚太传统医药,2009,5(3):3-4.

[14] 姜振,庄朋伟,张艳军. 中药复方血清药理学及其在药效评价中的应用[J]. 齐鲁药事,2010,29(2):96-98. DOI:10.3969/ j.issn.1672-7738.2010.02.016.

[15] Wang Y,Hao H,Wang G,et al. An approach to identifying sequential metabolites of a typical phenylethanoid glycoside, echinacoside,based on liquid chromatography-ion trap-time of flight mass spectrometry analysis[J]. Talanta,2009,80(2): 572-580. DOI:10.1016/j.talanta.2009.07.027.

[16] Jia C,Shi H,Jin W,et al. Metabolism of echinacoside,a good antioxidant,in rats:isolation and identification of its biliary metabolites[J]. Drug Metab Dispos,2009,37(2):431-438. DOI:10.1124/dmd.108.023697.

相似文献/References:

[1]于敏娜 胡海燕 王婷 王荣 徐红丹.基于血液代谢组学的升陷汤抗慢性心力衰竭的作用机制研究[J].国际中医中药杂志,2019,41(09):976.[doi:10.3760/cma.j.issn.1673-4246.2019.09.014]
 Yu Minna,Hu Haiyan,Wang Ting,et al.Mechanism of Shengxian decoction in treatment of heart failure based on serum metabolomics[J].,2019,41(09):976.[doi:10.3760/cma.j.issn.1673-4246.2019.09.014]

备注/Memo

通信作者:潘艳丽,Email: panely@163.com,电话:13810282912

基金项目:国家中医药管理局国家中药标准化项目(ZYBZH-Y-HUB-20)

更新日期/Last Update:

2020-09-17